Could a palm extract help fight a rare genetic brain disease?
NCT ID NCT04658823
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a supplement called HOV-12020 (made from palm tocotrienols) in 50 adults aged 45-75 with CADASIL, a rare genetic disease that damages small blood vessels in the brain, leading to strokes and memory loss. The goal was to see if the supplement could reduce worsening of symptoms like stroke, disability, or cognitive decline over 24 months. Participants were randomly assigned to receive either the supplement or a placebo, and neither they nor their doctors knew which they received.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CADASIL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Lariboisière APHP
Paris, 75010, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a sublingual tablet repair the Brain's leaky barrier in CADASIL?
- Could your own stem cells heal your brain? new trial tests it
- French biobank aims to unlock secrets of rare brain vessel diseases
- 10-Year study to track rare brain disease in 500 koreans
- Brain scans reveal hidden clues in rare stroke disorder
- Rare stroke causes no longer overlooked: new italian network aims to diagnose and understand mysterious brain diseases